Your browser doesn't support javascript.
loading
Autogenous Control of 5'TOP mRNA Stability by 40S Ribosomes.
Gentilella, Antonio; Morón-Duran, Francisco D; Fuentes, Pedro; Zweig-Rocha, Guilherme; Riaño-Canalias, Ferran; Pelletier, Joffrey; Ruiz, Marta; Turón, Gemma; Castaño, Julio; Tauler, Albert; Bueno, Clara; Menéndez, Pablo; Kozma, Sara C; Thomas, George.
Afiliación
  • Gentilella A; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain; Department of Biochemistry and Physiology, Faculty of Pharmacy, Universitat de Barcelona, 08028 Barcelona, Spain. Electronic addre
  • Morón-Duran FD; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Fuentes P; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Zweig-Rocha G; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Riaño-Canalias F; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Pelletier J; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Ruiz M; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Turón G; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain.
  • Castaño J; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, OH 45267-0508, USA.
  • Tauler A; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain; Department of Biochemistry and Physiology, Faculty of Pharmacy, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Bueno C; Josep Carreras Leukemia Research Institute and School of Medicine, University of Barcelona, 08916 Barcelona, Spain.
  • Menéndez P; Josep Carreras Leukemia Research Institute and School of Medicine, University of Barcelona, 08916 Barcelona, Spain; Institut Catala de Recerca i Estudis Avançats (ICREA) Lluis Companys, 08916 Barcelona, Spain.
  • Kozma SC; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, OH 45267-05
  • Thomas G; Metabolism and Cancer Group, Molecular Mechanisms And Experimental Therapy In Oncology Program, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona, Spain; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, OH 45267-05
Mol Cell ; 67(1): 55-70.e4, 2017 07 06.
Article en En | MEDLINE | ID: mdl-28673543
ABSTRACT
Ribosomal protein (RP) expression in higher eukaryotes is regulated translationally through the 5'TOP sequence. This mechanism evolved to more rapidly produce RPs on demand in different tissues. Here we show that 40S ribosomes, in a complex with the mRNA binding protein LARP1, selectively stabilize 5'TOP mRNAs, with disruption of this complex leading to induction of the impaired ribosome biogenesis checkpoint (IRBC) and p53 stabilization. The importance of this mechanism is underscored in 5q− syndrome, a macrocytic anemia caused by a large monoallelic deletion, which we found to also encompass the LARP1 gene. Critically, depletion of LARP1 alone in human adult CD34+ bone marrow precursor cells leads to a reduction in 5'TOP mRNAs and the induction of p53. These studies identify a 40S ribosome function independent of those in translation that, with LARP1, mediates the autogenous control of 5'TOP mRNA stability, whose disruption is implicated in the pathophysiology of 5q− syndrome.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleoproteínas / Proteínas Ribosómicas / Ribosomas / Autoantígenos / Biosíntesis de Proteínas / ARN Mensajero / Estabilidad del ARN / Secuencia de Oligopirimidina en la Región 5' Terminal del ARN Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleoproteínas / Proteínas Ribosómicas / Ribosomas / Autoantígenos / Biosíntesis de Proteínas / ARN Mensajero / Estabilidad del ARN / Secuencia de Oligopirimidina en la Región 5' Terminal del ARN Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2017 Tipo del documento: Article